AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
DESVENLAFAXINE SUCCINATE in Zimbabwe
2 products registered with MCAZ — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DESLAFAXOR 100 (EXTENDED RELEASE) TABLET, COATED; ORAL | 2021/13.2.1/6084 | INNOVATA PHARMACEUTICALS LTD | active | 31 Dec 2027 |
| DESLAFAXOR 50 (EXTENDED RELEASE) TABLET, COATED; ORAL | 2021/13.2.1/6083 | INNOVATA PHARMACEUTICALS LTD | active | 31 Dec 2027 |
DESVENLAFAXINE SUCCINATE — MCAZ Registration Details
MCAZ (Zimbabwe) has 2 registered products containing DESVENLAFAXINE SUCCINATE, of which 2 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track DESVENLAFAXINE SUCCINATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.